Page last updated: 2024-09-03

gefitinib and Neoplasms, Skull Base

gefitinib has been researched along with Neoplasms, Skull Base in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adkins, J; Byron, S; Cuyugan, L; Dardis, C; Enriquez, D; Helland, A; Liang, WS; Little, AS; Sekar, S	1

Other Studies

1 other study(ies) available for gefitinib and Neoplasms, Skull Base

Article	Year
Identification of therapeutic targets in chordoma through comprehensive genomic and transcriptomic analyses. Cold Spring Harbor molecular case studies, 2018, Volume: 4, Issue:6 Topics: Adult; Aged; Ataxia Telangiectasia Mutated Proteins; Checkpoint Kinase 2; Chordoma; Cyclin-Dependent Kinase 4; DNA-Binding Proteins; Female; Gefitinib; Gene Expression Profiling; Genomics; Humans; Male; Middle Aged; Mutation; Nuclear Proteins; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Pyridines; Receptor, ErbB-3; Receptor, Fibroblast Growth Factor, Type 1; Skull Base Neoplasms; Transcription Factors; Transcriptome	2018

Article

Year

Identification of therapeutic targets in chordoma through comprehensive genomic and transcriptomic analyses.

Cold Spring Harbor molecular case studies, 2018, Volume: 4, Issue:6

Topics: Adult; Aged; Ataxia Telangiectasia Mutated Proteins; Checkpoint Kinase 2; Chordoma; Cyclin-Dependent Kinase 4; DNA-Binding Proteins; Female; Gefitinib; Gene Expression Profiling; Genomics; Humans; Male; Middle Aged; Mutation; Nuclear Proteins; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Pyridines; Receptor, ErbB-3; Receptor, Fibroblast Growth Factor, Type 1; Skull Base Neoplasms; Transcription Factors; Transcriptome

2018